Curza is a small-molecule therapeutics company that has developed several structurally distinct classes of proprietary drugs focused on infectious diseases and oncology. Curza’s lead program is a new class of broad spectrum antibiotics, focused on ESKAPE pathogens and drug-resistant Gram-negative bacteria. Inspired by a natural product, thisclass targets an unexploited binding site of the bacterial ribosome. With ever increasing reports of resistance to frontline therapies addressing Gram-negative bacteria, there is a critical need for new therapies and new therapies that work in new ways. However, very little can be found in the development pipeline. As a result, Curza’s compounds are addressing a major unmet medical need.

Biotechnology

Health Care

Therapeutics

Curza

Curza's headquarters in Salt Lake City, UT, United States

Description

People (9)

Chad Testa

Dustin Williams

Geri Mackie

Nick Skene

Paul Sebahar

Ryan Looper

Daniel Zigar

Michael Landward

Travis Haussener

Jobs